A rare, brain-damaging disease faces a new foe: a $267K-a-year drug from a Bay Area stalwart

This North Bay rare disease drug developer won its seventh regulatory approval, a potential replacement for one of its oldest (and most financially successful) drugs.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news